Rationale: Thymosin beta 4 (T␤4) is a 43-amino acid factor encoded by an X-linked gene. Recent studies have suggested that T␤4 is a key factor in cardiac development, growth, disease, epicardial integrity, and blood vessel formation. Cardiac-specific short hairpin (sh)RNA knockdown of t␤4 has been reported to result in embryonic lethality at E14.5-16.5, with severe cardiac and angiogenic defects. However, this shRNA t␤4-knockdown model did not completely abrogate T␤4 expression. To completely ablate T␤4 and to rule out the possibility of off-target effects associated with shRNA gene silencing, further studies of global or cardiac-specific knockouts are critical.
I nsights into the functions of molecular factors involved in cardiovascular development and healing can improve our understanding of cardiac homeostasis and disease. 1 The use of these factors can provide novel therapeutic approaches to treat myocardial dysfunction. Thymosin beta 4 (T␤4) is a 43-amino acid-long peptide that was originally shown to bind G-actin and play a role in F-actin formation. [2] [3] [4] [5] [6] Recent studies have suggested that T␤4 is a key factor in cardiac development, growth, disease, epicardial integrity, and all 3 phases of blood vessel formation (angiogenesis, vasculogenesis, and arteriogenesis). [7] [8] [9] [10] [11] [12] [13] [14] [15] Indeed, murine and chick studies noted temporal and spatial regulation of T␤4 expression during embryonic development, neonatal development, and biomechanically induced pressure overload. 8 -12 Moreover, murine and porcine myocardial infarction and ischemia/reperfusion studies have demonstrated that postoperative exogenous administration of T␤4 improved cardiovascular function, abrogated scar formation, and improved myocyte survival. 8 -10,13 It has been reported that treatment with T␤4 before myocardial infarction can promote de novo cardiomyocyte formation after infarction; however, addition of T␤4 postinfarct does not promote de novo cardiomyocyte forma-tion. 14, 15 It has also been reported that administration of T␤4 reactivates a proangiogenic cascade and improves cardiac capillary bed formation. 13 Together, these data indicate that stimulation with T␤4 may have positive effects on vessel formation and may inhibit disease progression post cardiac injury.
Recently, it has been reported that short hairpin (sh)RNA knockdown of T␤4 specifically in an Nkx2.5-Cre expression domain results in significant cardiac developmental defects. 9 These data also suggested that T␤4 is pivotal in epicardialderived progenitor cell mobilization and differentiation into endothelial and vascular smooth muscle cells. However, this shRNA t␤4-knockdown model did not completely abrogate T␤4 expression. To completely ablate T␤4 and rule out the possibility of off-target effects associated with shRNA gene silencing, further studies of global or cardiac specific knockouts of T␤4 are critical.
To further investigate T␤4 loss of function, we generated global and cardiac-specific t␤4-knockout mice to examine cardiac function. Using these mice, we examined the myocardium and coronary vasculature during embryonic development and in the adult mouse. The results of our studies demonstrate that absence of t␤4 does not perturb overall embryonic development, heart development, and adult heart function and does not alter capillary formation or density in the murine heart. Thus, we conclude that T␤4 is dispensable for normal cardiac development and function, including coronary vessel formation.
Statistics
The data obtained from all analyses were measured for significance using either a Student t test or 2 analyses, with PϽ0.05 regarded as significant. All data are represented as meanϮSEM.
Figure 1. Generation of t␤4-knockout mice. A,
Targeting strategy, restriction map of genomic region of t␤4; in the middle is the targeted construct and at the bottom is the mutated loci after recombination. P1, P2, and P4 represent primer sites for genotyping. The gray rectangle denotes the targeted exon, which is the 2nd exon encoding the majority of the coding region. Black triangles indicate LoxP sites and black boxes indicate frt-NEO-frt cassettes. DTA indicates diphtheria toxic A chain gene; Neo, neomycin resistance gene. B, Detection of wild-type and mutated alleles by Southern blot analysis. DNA from electroporated embryonic stem cells was digested with EcoR V and analyzed by Southern blot analysis with the probe diagrammatically represented in A. The 9.1-kb and 5.5-kb bands represent wild-type and mutated alleles, respectively. C, PCR analysis of DNA isolated from female (t␤4 ϩ/ϩ , t␤4 Ϫ/Ϫ ) and male (t␤4 ϩ/y and t␤4 Ϫ/y ) mouse tails. D, Real-time PCR confirmation of global gene deletion from female (t␤4 ϩ/ϩ , t␤4 Ϫ/Ϫ ) and male (t␤4 ϩ/y and t␤4 Ϫ/y ) mouse hearts. E, Western analyses of adult male (t␤4 ϩ/y and t␤4 Ϫ/y ) mouse hearts (H), thymus (Th), lung (Lu), spleen (Sp), and brain (B). HA-tagged T␤4 isolated from COS cells were used as control, observed at approximately 4 kDa. F, Immunostaining from heart and liver from E11.5 t␤4 Wt and t␤4 ko mouse hearts and liver; T␤4 (green), DAPI (blue). 
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Results
Generation of t␤4-Global Knockout Mice
To explore the role of t␤4 in mouse cardiovascular development and function, we generated conditional alleles for t␤4 gene by homologous recombination in embryonic stem (ES) cells as described previously. 16 Briefly, we flanked the second exon for mouse t␤4, encompassing 75% of the coding sequence ( Figure  1A ). Targeted ES cells were confirmed using Southern blot analyses ( Figure 1B ). Chimeric males were then bred with black Swiss females to establish t␤4 f/ϩ;neoϩ mice. These mice were fertile, viable, and phenotypically normal (data not shown). Global deletion of t␤4 was achieved by crossing t␤4 f/ϩ;neoϩ mice with Mox2-Cre deleter mice (t␤4 f/y;creϩ ). 21 These mice were then crossed to black Swiss mice to establish t␤4 Ϯ and t␤4 Ϫ/y mice. t␤4 Ϫ/Ϫ mice were established by crossing t␤4 Ϯ and t␤4 Ϫ/r . Deletion of t␤4 was confirmed by using PCR from tails and real-time PCR from hearts ( Figure 1C and 1D). Deletion was further confirmed by Western blot analyses of adult heart, thymus, lung, spleen, and brain as well as immunostaining in E11.5 embryos ( Figure 1E and 1F ). Both t␤4 Ϫ/Ϫ and t␤4 Ϫ/y were born at predicted mendelian ratios (Table) . t␤4-deficient mice were then backcrossed to C57/B6 mice for 8 generations.
Again, we observed that both t␤4 Ϫ/Ϫ and t␤4 Ϫ/y mice were born at predicted mendelian ratios (Table) .
t␤4-Knockout Embryos Are Viable and Have Normal Blood Vessel Development
Early murine studies detected T␤4 in developing myocardium as early as E.8.0. 22 Later studies furthered these observations by characterizing temporal and spatial expression patterns of T␤4 in developing heart from E9.5 to E12.5. 8 These data suggested that T␤4 may be required for embryonic heart development. In keeping with this idea, embryonic lethality and significant cardiac defects were observed in mice with shRNA t␤4-knockdown in Nkx2.5-Cre lineages. 9 In contrast, our t␤4-knockout mice did not present with embryonic lethality, even in different genetic backgrounds. The possibility remained that global t␤4-knockout mice would display some cardiac abnormalities during embryonic development.
To assess whether t␤4-knockout mice displayed any abnormalities during heart development, we examined global t␤4-knockout embryos at E14.5. No cardiac or other gross anatomic abnormalities were observed in global knockout embryos when compared with wild-type controls ( Figure  2A ). Histological examination of t␤4-knockout hearts did not exhibit abnormalities in development of compact myocardium, detachment of the epicardium, changes in the epicardial marker Wt1 (Wilms tumor protein), or presence of nodules on the epicardial surface ( Figure 2B and Figure3A). Stimulation with T␤4 recombinant protein activated vascular endothelial growth factor (VEGF) and vessel formation in a chick chorioallantoic membrane angiogenesis model. 23 Previous studies suggested that T␤4 activates epicardiumderived cells to migrate in and differentiate into endothelial or smooth muscle cells (SMC). 9 Therefore, we further characterized the embryonic heart by immunohistological examination of the microvasculature. Our analyses revealed that formation and distribution of CD31-positive cells throughout the myocardium was not changed in t␤4-knockout hearts relative to control littermate hearts ( Figure 2C and 2D). These data suggested that t␤4 loss had no deleterious effects on coronary angiogenesis. Moreover, quantitative assessment demonstrated no difference in the number of CD31-positive endothelial cells per field in t␤4-knockout E14.5 hearts relative to hearts from littermate controls ( Figure 2E) .
Given that epicardium-derived cells also contribute to SMCs and that t␤4 loss may alter invasion of these cells into myocardium, we also examined the pattern and distribution of ␣-smooth muscle actin (␣SMA)-positive cells. These immunostaining data revealed that both control and knockout fetal hearts displayed normal distributions of ␣SMAϩ cells (Figure 2C ). Finally, immunostaining of large vessels at E14.5 revealed normal SMAϩ SMC and CD31ϩ endothelial cell layers. Again, defects were not evident either at the histological or cellular levels ( Figure 2B and 2D ). Together, these data indicate that global loss of T␤4 does not alter the development of coronary vessels.
t␤4-Global Knockout Mice Do Not Have Altered Adult Cardiac Function or Pathology
Given that t␤4-knockout animals were viable, without cardiac defects in midgestation embryos, and born at predicted mendelian ratios (Table) , we examined adult t␤4-global knockout mice for the presence of cardiac abnormalities. t␤4-global knockout mice had normal morphology and heart weight/body weight and heart weight/tibia length ratios when compared with control mice (Figure 4A , 4B, 4F, and 4G,). No changes were observed in expression of epicardial markers wt1, tbx18, or the closely related Thymosin factor, t␤10, by real-time PCR analyses (Figure 3B , 3C, and Online Figure I,  A) . Moreover, no significant changes were observed in cardiac fetal gene markers at 12 weeks of age (Online Figure  II, A through D) . Furthermore, no change in myocyte size was observed in global t␤4-knockout mice when compared with control mice (Figure 4E and 4H ). Previous studies of T␤4 stimulation during myocardial infarction and transverse aortic constriction in mice reported decreased fibrosis and procollagen-1␣1 and procollagen-3␣1 transcript activation. 8, 24 Histological and molecular examination of t␤4global knockout hearts revealed no fibrosis or fibrotic gene activation ( Figure 4C , 4D, and Online Figure II , E and F). These data demonstrated that t␤4 loss does not result in morphological abnormalities in adult heart. We also examined cardiac function by means of echocardiographic analyses of t␤4-global animals up to 12 months of age and did not observe any significant difference between knockout and wild-type control littermates (Online Table II ). In addition, no changes in survival were observed over the 12-month time course (data not shown).
t␤4-Global Knockout Mice Do Not Have Altered Coronary Capillary Bed Density or Angiogenic Gene Activation
Previous observations demonstrated that t␤4 is significantly unregulated during neonatal development. 11 This expression correlates with the increase in coronary capillary density observed in the first 3 weeks of the murine neonatal period. 25 Given that T␤4 simulation can activate proangiogenic markers in a murine myocardial adult infarct model, we postulated that t␤4 loss could cause a subtle decrease in the capillary bed volume in the adult mouse heart. To examine vascular density, we used coronary perfusion with FluroSpheres red (580/605 nm) and CD31 vessel staining as previously described. 19 To calculate volume, 30-m-thick sections were imaged and 3-dimensional reconstructions were examined. Representative reconstructions revealed no major changes in vessel arrangement. Moreover, quantitative analyses indicated that capillary volume or CD31-positive vessels were not reduced in the t␤4-deficient animals when compared with wild-type controls ( Figure 5A and 5C ). To further support these results, we examined key proangiogenic molecular markers found to either be upregulated by T␤4 simulation or altered in vascular deficiency. 13 Real-time PCR analyses found no significant changes in factors previously found to be Furthermore, levels of CD31, Tie2, and Flt-1 were not altered in our t␤4-deficient mouse model ( Figure 5B ).
Cardiac-Specific Deletion of t␤4 Mice Does Not Result in Embryonic Lethality or Cause Adult Abnormal Cardiac Function
We generated cardiac specific t␤4-deficent mice using both the Nkx2.5-Cre and ␣MHC-Cre drivers. Initially, we crossed t␤4 f/ϩ;neoϩ mice to FLPe recombinase mice 26 to delete the neocassette, to avoid potential effects of the neocassette on normal t␤4 expression. t␤4 f/ϩ mice were then crossed to homozygosity and subsequently crossed to either Nkx2.5-Cre 27 or ␣MHC-Cre 28,29 mice to generate cardiac-specific t␤4-knockouts (t␤4 f/y;nkx-creϩ , t␤4 f/y;amhc-creϩ ). Neither line displayed embryonic lethality, and both were viable to adulthood. Given these observations, we examined t␤4 f/y;nkx-creϩ mice in greater detail. t␤4 f/y;nkx-creϩ knockout efficiency was confirmed in isolated adult cardiomyocytes and found to be Ϸ80% (Online Figure III) . Adult t␤4 f/y;nkx-creϩ mice did not have alterations in heart weight/body weight or heart weight/ tibia length compared with control mice (t␤4 f/y ) (Figure 6A  and 6B ). Detailed histological observations as well as expression of fetal gene and fibrotic markers were also similar to control mice ( Figure 6C through 6J) . Echocardiographic analysis at 12 weeks of age demonstrated that t␤4 f/y;nkx-creϩ mice have normal cardiac function, chamber size, and wall thickness compared with their littermate controls (Online Table III ). Coronary perfusion with FluroSpheres red (580/ 605 nm) also demonstrated no changes in vessel volume in the t␤4 f/y;nkx-creϩ mouse (Online Figure IV, A and B ).
Discussion
Characterization of factors that drive heart formation, coronary angiogenesis, and vasculogenesis is critical for understanding both development and disease progression. Indeed, proangiogenic factor expression can drive a physiological response to disease stimuli (hypertension/myocardial infarct). 19, 25, 30, 31 Recent studies have suggested that T␤4 is essential for cardiac development and angiogenesis. 9 To understand the role of T␤4, we generated global and cardiacspecific knockout mice. We observed that global or cardiacspecific loss of t␤4 did not cause either a significant embryonic or adult cardiovascular phenotype, with no embryonic lethality, and no age-related decline in cardiovascular function. Our data demonstrated that t␤4 global knockout mice, regardless of genetic background (mixed 129svj and black Swiss or pure C57/B6), were not embryonic lethal. Indeed, no cardiac or gross abnormalities were observed in global knockout embryos or hearts. Moreover, t␤4-knockout hearts did not reveal any defects in compact myocardium, epicardial detachment, or presence of nodules on the epicardial surface. We also performed quantitative assessment of CD31-positive endothelial cells in E14.5 hearts and found no significant differences between t␤4-knockout and control hearts. These data suggested that t␤4 loss had no deleterious effects on angiogenesis. These data are in contrast with data obtained with Nkx2.5-Cre-specific shRNA t␤4-knockdown mice, which display significant lethality at E14.5-16.5, with severe cardiac developmental and angiogenesis defects. 9 Given that t␤4-knockout animals were viable, we examined adult t␤4-global and cardiac-specific knockout mice for the presence of cardiac abnormalities. Our t␤4-knockout mice did not have any observable histological defects and did not exhibit any abnormalities in fetal gene markers or cardiac function. Taken together, these data demonstrated that global or cardiac-specific deletion of t␤4 did not result in a patho-logical phenotype, further illustrating that T␤4 is dispensable for normal cardiac development and function.
T␤4 has a suggested role in coronary angiogenesis. 9 We did not observe any defects in coronary vessel formation during embryonic development in our mutant mice. Given these observations, we studied adult global t␤4-knockout mice for the possibility of angiogenic defects. On examination of adult capillary bed density and volume, we observed that t␤4 loss did not alter coronary vasculature density or volume. These data demonstrated that t␤4 loss does not affect blood vessel density in the adult animal.
Published data show that cardiac-specific shRNA t␤4knockdown mice, using an Nkx2.5-Cre driver, display signif- icant lethality at E14.5-15.5 with abnormal cardiac development. 9 However, our global t␤4-knockout mice have normal cardiac development and function without any embryonic lethality. To exclude the possibility that global deletion of t␤4 results in a compensatory mechanism to replace t␤4 loss, thus accounting for the observed discrepancies between the two mouse models, we generated cardiac-specific t␤4-deficent mice, using either Nkx2.5-Cre or ␣MHC-Cre drivers. Our data demonstrated that cardiac-specific deletion of t␤4 did not result in embryonic lethality, defects in cardiac development and function, or coronary vasculature abnormalities, further illustrating that T␤4 is dispensable for normal cardiac development and function.
Differences between results of our study and that of shRNA knockdown of T␤4 probably result from the distinct experimental approaches used for inhibiting/blocking T␤4. A strong possibility is that the shRNA approach had off-target effects. Our model is a total ablation of T␤4, as demonstrated by Western blot and immunostaining analyses. Thus, we believe, given the model system and approach used in our study, that we have demonstrated that T␤4 is dispensable for cardiac development, coronary vessel formation, and cardiac function.
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Novelty and Significance
What Is Known?
• Thymosin beta 4 (T␤4) is an X-linked, small (44aa), ubiquitously expressed protein. • T␤4 has been shown to bind in a 1:1 ratio with G-actin. • Cardiac-specific shRNA knockdown of t␤4, using an Nkx2.5-cre driver in mice, resulted in abnormal development of compact myocardium and coronary vasculature and significant embryonic lethality between E14.5 and E16.5.
What New Information Does This Article Contribute?
• Global and cardiac-specific deletion of T␤4 does not result in lethality. • Global and cardiac-specific t␤4-knockout mice do not display any cardiac pathology, coronary vasculature defects, or functional defects. • T␤4 is dispensable for viability, heart development, coronary vessel development, and adult myocardial function.
It has been previously shown that shRNA cardiac-specific knockdown of T␤4, using the Nkx2.5-cre driver, resulted in significant cardiac and coronary vessel defects. That study concluded that T␤4 was critical for the formation of the coronary vasculature and the embryonic myocardium. Those data also suggested that T␤4 is pivotal in epicardial-derived progenitor cell mobilization and differentiation into endothelial and vascular smooth muscle cells. However, T␤4 expression was not completely ablated, and the shRNA might have had off-target effects. Thus, to understand the role of T␤4, we generated floxed alleles for t␤4 and established global and cardiac-specific deletion models of t␤4. We observed that both global and cardiac-specific t␤4-knockout mice were viable. Detailed analyses of global t␤4-knockout embryos found no defects in coronary vasculature formation, cardiac development, or epicardial development. Moreover, global t␤4-knockout mice did not exhibit adult heart pathology, cardiac functional defects, or alterations in the coronary vasculature. Cardiac-specific t␤4-knockout mice had no overtly detectable pathological phenotype, exhibiting normal heart and coronary vessel development. Thus, we conclude that T␤4 is dispensable for viability, heart development, coronary vessel development, and adult myocardial function.
